IDH1 and central nervous system cancer: However, by excluding the patients with isocitrate dehydrogenase 1 (IDH1) mutation, we found that all types of glioma patients displayed much lower DNA 6mA content compared to the normal tissues and no statistic difference in between (Fig. 3c).